LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q4 2023

Top Holdings332 positions

Checking export access…
Activity:
??MONGODB INCDelisted
Bond
159M$314.4M3.0%———
Increased
71
??LI AUTO INCDelisted
Bond
205M$300.1M2.9%——
7 qtrssince 2022-Q2
Increased
54
??SEA LTDDelisted
276.5M$264M2.5%———
Increased
53
69.1M$251.3M2.4%———
Increased
85
??ROYAL CARIBBEAN GROUPDelisted
Bond
86.4M$230.2M2.2%———
Unchanged
0
??BILL HOLDINGS INCDelisted
Bond
211.9M$199.3M1.9%———
Increased
56
??BILIBILI INCDelisted
Bond
180.2M$177.8M1.7%——
15 qtrssince 2020-Q2
Increased
48
??LIVONGO HEALTH INCDelisted
Bond
187.1M$175.3M1.7%———
Decreased
0
??CONFLUENT INCDelisted
Bond
205.2M$171.6M1.6%———
Increased
49
165.2M$167.5M1.6%———
Increased
51
??WOLFSPEED INCDelisted
Bond
136.8M$156.3M1.5%———
Decreased
0
??SNAP INC
Bond
183.2M$144.4M1.4%———
Increased
49
171.8M$139.1M1.3%———
Increased
53
??SEA LTD
Bond
160.5M$132.4M1.3%———
Increased
56
167.3M$132.3M1.3%——
4 qtrssince 2023-Q1
Unchanged
0
145.9M$131.6M1.3%———
Increased
53
143.2M$127.4M1.2%———
New
69
??CERIDIAN HCM HLDG INCDelisted
Bond
141.1M$127.1M1.2%———
Decreased
0
153.7M$127.1M1.2%———
Decreased
0
??LYFT INCDelisted
Bond
119.6M$113.9M1.1%———
Increased
47
$10.5B
AUM
332
Positions
Q4 2023
Filing
HI score · 2.5/5
Quarterly 13F Value Change
+0%Q3'22$10.9B-13%Q4'22$9.5B-0%Q1'23$9.5B+0%Q2'23$9.5B+2%Q3'23$9.7B+8%Q4'23$10.5B
Activity profile
$ moved · Q4'23
New19%Increased40%Decreased27%Exited14%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.5 years
<1Q9%1-4Q20%1-2Y39%2Y+31%

LINDEN ADVISORS LP manages $10.5B across 332 positions as of Q4 2023. Top holdings: MONGODB INC (3.0%), LI AUTO INC (2.9%), SEA LTD (2.5%). Fund DNA: Momentum Trader. HoldingsIntel Score: 2.5/5.0.

Q4 2023 Summary

Active quarter - 36 new positions, 78 exits, 87 increased. No standout high-conviction moves this quarter. Portfolio: $10.5B across 332 positions.

Top holdings by portfolio weight

Total AUM$11B
MONGODB INC2.99%
LI AUTO INC2.86%
SEA LTD2.51%
UNITED STATE2.39%
ROYAL CARIBB2.19%
BILL HOLDING1.90%
BILIBILI INC1.69%
LIVONGO HEAL1.67%
CONFLUENT IN1.63%
SAREPTA THER1.59%
Other1.49%

Portfolio allocation by GICS sector

Sectors8
Unknown41.55%
Financial Services28.89%
Technology19.58%
Basic Materials8.00%
Industrials1.00%
Energy0.73%
Utilities0.17%
Healthcare0.09%

Behavioral investing profile

Checking access…
Momentum Trader
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L57
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+151.4M shares+$192.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC.
Q4 2024 → Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 → Q2 2026+26.6M shares+$50.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used